Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × Methods × Clear all

Sponsor

Conditions

Colorectal Neoplasms 4 Breast Neoplasms 4 Neoplasms 3 Head and Neck Neoplasms 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Wake Disorders 1 Sleep Initiation and Maintenance Disorders 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Obesity 1 Multiple Myeloma 1 Mucositis 1 Motor Activity 1 Lymphoma 1 Lymphoid Interstitial Pneumonia 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Diabetes Mellitus 1 Coronary Disease 1 Chronic Disease 1 Breast, Cervical or Colorectal Cancer Screening Needed 1 Bone Neoplasms 1 Body Weight Changes 1 Abnormalities, Radiation-Induced 1

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 ioflupane 1 aflibercept 1 Water 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡